About Applied spectral imaging
Applied Spectral Imaging (ASI) is a leading provider of innovative imaging solutions for cytogenetic, pathology and research laboratories. With a focus on cancer testing, ASI offers brightfield, fluorescence and spectral imaging technologies that enable researchers to visualize and analyze cells with unprecedented clarity and precision.
At the heart of ASI's technology is its proprietary spectral imaging platform, which allows researchers to capture images across a wide range of wavelengths. This enables them to distinguish between different types of cells and identify subtle changes in their morphology or behavior that may be indicative of disease.
One key application of ASI's technology is in the field of cytogenetics, where it is used to analyze chromosomes for abnormalities such as translocations or deletions. By combining brightfield and fluorescence imaging with spectral analysis, ASI's systems can detect even subtle changes in chromosome structure that might otherwise go unnoticed.
In addition to its cytogenetics applications, ASI's technology has also been used in pathology research to study the progression of cancer at the cellular level. By analyzing tissue samples using both brightfield and fluorescence microscopy techniques, researchers can gain insights into how tumors develop and spread over time.
Another area where ASI has made significant contributions is in the development of new cancer therapies. By using spectral imaging techniques to study how different drugs interact with cancer cells at the molecular level, researchers can identify promising candidates for further testing.
Overall, Applied Spectral Imaging represents an exciting new frontier in medical research. With its cutting-edge technologies and commitment to innovation, it is poised to make significant contributions towards our understanding of cancer biology – ultimately leading us closer towards more effective treatments for this devastating disease.